Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3389699 Title: ANTICORPS MONOCLONAUX CHIMÉRIQUES ET HUMANISÉS ANTI-CTLA4 HUMAINE, ET LEURS UTILISATIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
168766129
WO application number:
US2016066698
Type:
European patent granted for BE
Status:
Open
Publication number:
3389699
WO publication number:
WO2017106372
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
14/12/2016
Grant date:
01/05/2024
EP publication date:
24/10/2018
WO publication date:
22/06/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
01/05/2024
EP B1 publication date:
01/05/2024
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
14/12/2036

Applicant

Name:
OncoC4, Inc.
Legal Form:
From:
01/05/2024
Address:
9640 Medical Center Drive, Rockville, MD 20850, United States (US)
To:

Agent

Name:
MEYER Hans-Joachim
Legal Form:
From:
29/05/2024
Address:
Postfach 10 18 30, 40009, DÜSSELDORF, Germany (DE)
To:

Inventor

1

Name:
LIU, Yang
Legal Form:
Address:
Washington, District of Columbia 20002, United States (US)

2

Name:
ZHENG, Pan
Legal Form:
Address:
Washington, District of Columbia 20002, United States (US)

3

Name:
DEVENPORT, Martin
Legal Form:
Address:
Gaithersburg, Maryland 20878, United States (US)

Priority

1

Priority patent number:
201662359036 P
Priority date:
06/07/2016
Priority country:
United States (US)

2

Priority patent number:
201662309169 P
Priority date:
16/03/2016
Priority country:
United States (US)

3

Priority patent number:
201562267735 P
Priority date:
15/12/2015
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07K 16/28; A61K 39/395; A61P 35/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2024/09
Publication date:
27/05/2024
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202418
Publication date:
01/05/2024
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/01/2026
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
18/12/2024
Last annual fee paid number:
9
Last annual fee paid amount:
165 Euro
Payer:
COHAUSZ & FLORACK
Filing date Document type Publication Type Document Description Number of pages File Type
29/05/2024 Incoming Correspondence (Post) 1 PDF /1/0/4/1/2/0722421401/docs/168766129_0_incomingcorrespondencepaper_20240530_041042351.pdf